An experimental COVID-19 vaccine developed by Taiwanese maker Adimmune Corp. has been given conditional approval to enter human trials, according to Taiwan's Food and Drug Administration (FDA) on Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Lunar New Year train tickets to go on sale mid-January
12/16/2025 08:56 PM - Sports
Steven Moya re-signs with TSG Hawks
12/16/2025 08:28 PM - Society
Taiwanese tea wins prize in France amid Chinese political protest
12/16/2025 08:18 PM - Business
Taiwan economic success down to 'inclusive institutions': Nobel winner
12/16/2025 06:45 PM - Society
Taiwan NPOs offered free 'green domain' certification to fight phishing
12/16/2025 06:43 PM